SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001123292-18-001125
Filing Date
2018-12-21
Accepted
2018-12-21 16:53:54
Documents
2
Period of Report
2018-12-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 5062
2 mmcelhaughpoa2.htm EX-24 3438
  Complete submission text file 0001123292-18-001125.txt   10041
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ONCORE BIOPHARMA, INC. 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address
McElhaugh Michael J. (Reporting) CIK: 0001635326 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34949 | Film No.: 181250246